Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist
- 5 September 1995
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 283 (1-3), 63-72
- https://doi.org/10.1016/0014-2999(95)00287-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonistBioorganic & Medicinal Chemistry Letters, 1994
- Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtypeBritish Journal of Pharmacology, 1993
- Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistBiochemical Pharmacology, 1993
- Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- Endothelin stimulates 86Rb efflux in rat glioma C6-Bu-1 cellsNeuropeptides, 1991
- DuP 532: A second generation of nonpeptide angiotensin II receptor antagonistsBiochemical and Biophysical Research Communications, 1991
- 1-(Carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonistsJournal of Medicinal Chemistry, 1991
- Identification of angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989
- Chronic vascular constrictions and measurements of renal function in conscious ratsKidney International, 1979